Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-20 of 51
Keywords: Corticosteroids
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
1
Sort by
Journal Articles
Julia-Tatjana Maul, Florian Anzengruber, Curdin Conrad, Antonio Cozzio, Peter Häusermann, Ahmad Jalili, Antonios G.A. Kolios, Emmanuel Laffitte, Anne-Karine Lapointe, Carlo Mainetti, Christoph Schlapbach, Ralph Trüeb, Nikhil Yawalkar, Michaela Dippel, Alexander A. Navarini
Journal:
Dermatology
Dermatology (2021) 237 (2): 166–178.
Published Online: 06 January 2021
... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Psoriasis Topical management Fixed combination Corticosteroids Calcineurin inhibitors Vitamin D 3 analogues Consensus Guidelines Dermatology 2021;237:166 178 DOI...
Journal Articles
Journal:
Dermatology
Dermatology (2018) 233 (5): 333–343.
Published Online: 08 December 2017
...Uffe Nygaard; Mette Deleuran; Christian Vestergaard Atopic dermatitis is a chronic inflammatory skin disorder affecting children and adults, with the majority presenting mild to moderate disease severity. The use of topical corticosteroids (TCSs) in combination with emollients has been the mainstay...
Journal Articles
Journal:
Dermatology
Dermatology (2017) 233 (2-3): 136–140.
Published Online: 29 July 2017
... any additional adverse effects, also relying on the short bioavailability of prednisolone. We propose a shift from the previously described schemes with a 2-week corticosteroid treatment [ 12 ] or 4 weeks of steroid treatment before starting isotretinoin [ 6 ], being in line with the proposal...
Journal Articles
Diane Kottler, Stéphane Barète, Gaelle Quéreux, Saskia Ingen-Housz-Oro, Sylvie Fraitag, Nicolas Ortonne, Lydia Deschamps, Michel Rybojad, Béatrice Flageul, Béatrice Crickx, Anne Janin, Martine Bagot, Maxime Battistella
Journal:
Dermatology
Dermatology (2015) 231 (4): 367–377.
Published Online: 10 October 2015
...% relapse. Oral corticosteroids had 100% response with 50% relapse. Thalidomide, cyclosporine or interferon-α had 100% response, but 100, 20 and 50% relapse, respectively. KD showed clinicopathological similarities with 27 published cases of cutaneous IgG4-RD. Conclusion: Surgery may be used in resectable...
Journal Articles
Journal:
Dermatology
Dermatology (2015) 231 (3): 286–290.
Published Online: 08 August 2015
... 10 mg methotrexate weekly. Group 2 patients received corticosteroid OMP which comprised tablets of dexamethasone 2.5 mg (5 tablets), taken on 2 consecutive days in a week (total weekly dose of 5 mg dexamethasone). Results: In the MTX group, among 25 patients analyzed, during the course of treatment...
Journal Articles
Journal:
Dermatology
Dermatology (2015) 230 (4): 308–313.
Published Online: 04 March 2015
... hypertrichosis. Objective: To compare the efficacy and safety of bimatoprost to those of corticosteroid in the treatment of scalp AA. Methods: Thirty adult patients with patchy AA (S 1 ) were included. Two AA patches were randomly assigned to treatment either by mometasone furoate 0.1% cream once daily (area...
Journal Articles
Journal:
Dermatology
Dermatology (2015) 230 (1): 11–15.
Published Online: 18 November 2014
... There are very few reports of treatment outcomes for IVRB. Table 1 presents a summary of the existing literature to our knowledge. Treatment with topical corticosteroids and topical calcipotriol resulted in improvement of the raised border surrounding the depigmented lesions in some cases; however, there were...
Journal Articles
Journal:
Dermatology
Dermatology (2014) 229 (2): 110–115.
Published Online: 14 August 2014
...Damjan S. Nikolic; Charis Ziori; Maria Kostaki; Lionel Fontao; Jean-Hilaire Saurat; Gürkan Kaya Background: Dermatoporosis is an emerging clinical condition caused by chronological skin aging, long-term sun exposure and chronic use of corticosteroids; however, genomic expression in dermatoporosis...
Journal Articles
S. Gregoriou, S. Giatrakou, K. Theodoropoulos, A. Katoulis, P. Loumou, E. Toumbis-Ioannou, E. Papadavid, G. Avgerinou, N. Stavrianeas, D. Rigopoulos
Journal:
Dermatology
Dermatology (2014) 228 (2): 158–165.
Published Online: 15 February 2014
.... Pemphigus Rituximab Treatment Remission Corticosteroids Immunosuppressants Pemphigus vulgaris is a potentially fatal blistering mucocutaneous autoimmune disease that affects the skin, oral cavity and other mucosal surfaces [ 1,2 ]. The advent of corticosteroids has improved prognosis...
Journal Articles
Journal:
Dermatology
Dermatology (2013) 227 (1): 37–44.
Published Online: 31 August 2013
... the effectiveness and side effects of intravenous high-dose pulse corticosteroids in children with alopecia areata and to identify prognostic factors for successful treatment. Methods: Patients treated with pulse corticosteroids for alopecia areata in 2001-2008 at the day care unit of a tertiary pediatric medical...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 47–65.
Published Online: 05 November 2009
...B.W. Barry This paper reviews our modification of the vasoconstrictor (blanching) assay for topical corticosteroids using human volunteers, which we have improved and extended so that it may be used as a useful screening test for clinical efficacy besides being employed to determine...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 91–100.
Published Online: 05 November 2009
...G. Stüttgen Following epimucous application of corticosteroids on the lips, narrowing and shortening of the terminal network of vessels occurs within 5–7 min. The decrease in infrared radiation needs a few more minutes. Contrary to the application of epinephrine-like substances, the change...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 239–246.
Published Online: 05 November 2009
... treatment and 12 were pretreated with betamethasone valerate (BMV). Tetracycline was given all the time as additional treatment. Clinically there was no significant difference between TA and HC 17-B. No rebound phenomenon was observed. If corticosteroids are to be used at all in rosacea or rosacea-like...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 107–115.
Published Online: 05 November 2009
...Wilson Jones The histological changes induced by 1 month’s applications of various corticosteroids to normal forearm skin were studied. Marked epidermal atrophy was present at 1 month with the more potent steroids, but the dermal changes were minimal or absent. The methods outlined in this study...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 173–180.
Published Online: 05 November 2009
...D.D. Munro All clinically effective topical corticosteroids have the potential for suppressing the pituitary-adrenal axis if large amounts are applied under occlusion on extensive areas. Recovery of the axis function occurs rapidly. In children, however, the risk of chronic suppression...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 133–137.
Published Online: 05 November 2009
...K. Király; Gy. Soós The vasoconstriction caused by four topical corticosteroid preparations was compared according to subjective ranking and according to measurement by a tristimulus colourimeter (Momcolor®). The measured results agreed well with visual evaluation. The colourimeter was proved...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 11–25.
Published Online: 05 November 2009
...Howard I. Maibach This paper reviews the percutaneous penetration of corticosteroids in vivo in man utilizing urinary excretion of 14 C-hydrocortisone as the experimental method. In general corticosteroids are only minimally absorbed from most areas of glabrous skin. Increasing the amount...
Journal Articles
Journal:
Dermatology
Dermatologica (1976) 152 (Suppl. 1): 37–46.
Published Online: 05 November 2009
...M. Ponec Results of in vitro studies on the penetration of a corticosteroid hydrocortisone 17-butyrate (HCB) in relation to the vehicle are reported. When HCB is dissolved completely in the vehicle, penetration is enhanced, and only under this condition an increase in HCB concentration...
Journal Articles
Journal:
Dermatology
Dermatologica (1973) 146 (1): 55–60.
Published Online: 16 October 2009
...I. Singh; N.N. Sharma; H.N. Seth; M.L. Gaind Beta-adrenergic blocking agents have a significant corticosteroid-sparing effect in the treatment of pemphigus vulgaris. In 18 patients, observations over a period of 8-27 months have shown that, in terms of percentage of the maintenance dose...
Journal Articles
Journal:
Dermatology
Dermatologica (1975) 150 (3): 136–153.
Published Online: 15 October 2009
...Harvey Baker Notwithstanding the intense interest in systemic cytotoxic therapy in recent years, the great majority of psoriatics are likely to go on needing topical therapy with tar, dithranol or corticosteroids, and a welcome trend is the spreading of interest in day care centres such as those...
1